Brief: Nicox’S NCX 470 Gets Approval By Chinese Authorities For Local Start Of Denali Phase 3 Trial

Nicox SA

04/03/2021 06:40

March 4 (Reuters) - NICOX SA  NCOX.PA :
    * REG-NICOX’S NCX 470 RECEIVES APPROVAL BY CHINESE
AUTHORITIES FOR
LOCAL START OF DENALI PHASE 3 TRIAL
    * APPROVAL FROM CHINA'S CENTER FOR DRUG EVALUATION OF
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION
    * APPROVAL TO CONDUCT CHINESE PART OF ONGOING NCX 470 DENALI
PHASE
3 CLINICAL TRIAL FOR LOWERING OF IOP IN PATIENTS WITH OPEN ANGLE
GLAUCOMA OR OCULAR HYPERTENSION.
    * ITS PARTNER, OCUMENSION THERAPEUTICS, HAS RECEIVED
APPROVAL FROM
CHINA'S CENTER FOR DRUG EVALUATION OF NATIONAL MEDICAL PRODUCTS
ADMINISTRATION TO CONDUCT CHINESE PART OF ONGOING NCX 470 DENALI
PHASE 3 CLINICAL TRIAL

Source text for Eikon:  ID:nGNEw4TmR 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))